Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Dabbs

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Pathology|February 20, 2015
Dual HER2 gene protein assay: focused study of breast cancers with 2+ immunohistochemical expressionZaibo Li, David J Dabbs, Kristine L Cooper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 21, 2012
Morphologic features do not influence response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancerXin Li, Amal Kanbour-Shakir, David J Dabbs, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 11, 2008
Evaluation of morphologic features to identify "basal-like phenotype" on core needle biopsies of breastMamatha Chivukula, Joan M Striebel, Cağatay Erşahin, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2009
Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?Rosemary A Recavarren, Mamatha Chivukula, Gloria Carter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Semi-quantitative immunohistochemical assay versus oncotype DX(®) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance studyJames A Kraus, David J Dabbs, Sushil Beriwal, et al.
Archives of Pathology & Laboratory Medicine|September 1, 2004
Epidermoid metaplasia of the cervixDiana N Ionescu, Deepak Mohan, Gloria Carter, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 27, 2010
Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptorsSiobhan M O'Connor, Sushil Beriwal, David J Dabbs, et al.
The American Journal of Surgical Pathology|April 27, 2007
The clinical significance of lobular neoplasia on breast core biopsyRouzan G Karabakhtsian, Ronald Johnson, Jules Sumkin, et al.
American Journal of Clinical Pathology|June 14, 2014
Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomasBeth Z Clark, Surabhi Beriwal, David J Dabbs, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 6, 2009
Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFRRohit Bhargava, Sushil Beriwal, Joan M Striebel, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Pathology|February 20, 2015
Dual HER2 gene protein assay: focused study of breast cancers with 2+ immunohistochemical expressionZaibo Li, David J Dabbs, Kristine L Cooper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 21, 2012
Morphologic features do not influence response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancerXin Li, Amal Kanbour-Shakir, David J Dabbs, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 11, 2008
Evaluation of morphologic features to identify "basal-like phenotype" on core needle biopsies of breastMamatha Chivukula, Joan M Striebel, Cağatay Erşahin, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2009
Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?Rosemary A Recavarren, Mamatha Chivukula, Gloria Carter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Semi-quantitative immunohistochemical assay versus oncotype DX(®) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance studyJames A Kraus, David J Dabbs, Sushil Beriwal, et al.
Archives of Pathology & Laboratory Medicine|September 1, 2004
Epidermoid metaplasia of the cervixDiana N Ionescu, Deepak Mohan, Gloria Carter, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 27, 2010
Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptorsSiobhan M O'Connor, Sushil Beriwal, David J Dabbs, et al.
The American Journal of Surgical Pathology|April 27, 2007
The clinical significance of lobular neoplasia on breast core biopsyRouzan G Karabakhtsian, Ronald Johnson, Jules Sumkin, et al.
American Journal of Clinical Pathology|June 14, 2014
Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomasBeth Z Clark, Surabhi Beriwal, David J Dabbs, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 6, 2009
Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFRRohit Bhargava, Sushil Beriwal, Joan M Striebel, et al.
Pageof 13